Outreach to accelerate drug development and clinical trials for cancer at UCR and City of Hope
Official title: Outreach
Funded at University of California Riverside · NIH-11411342 · Data updated 2026-11-12
A partnership between UC Riverside and City of Hope aims to build drug development resources and training to move ideas from local universities into cancer therapies and clinical trials for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $222,570 |
| NIH project number | 5U54CA285114-04 |
| Project ID | NIH-11411342 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include local students, postbaccalaureate trainees, and early-career researchers from the catchment area who are interested in cancer drug development and clinical trials.
✕Less likely to help
Patients not directly involved in drug development activities or those outside the catchment area may not directly benefit from this training-focused grant.
What this research studies
This program creates a Research Education Core to connect basic science with drug development and clinical trials in cancer. It will provide hands-on experiences and curriculum for students and postbaccalaureates to learn how drugs are discovered, translated to therapy, and tested in trials. The effort also includes training in ethics and HIPAA to prepare the next generation of clinical trialists. Through rotations at City of Hope laboratories and CRC training at the partner sites, participants will gain pathways to graduate school and medical training with a focus on translational cancer research.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of new cancer therapies and more skilled researchers capable of advancing drugs to clinical trials.
How similar studies have gone: Similar translational training programs have shown that structured pathways can increase participation in drug development and clinical trials.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Lo, David D — University of California Riverside
- Study coordinator: Lo, David D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.